← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 30, 2014Last known activity
Oct 16, 2025
Timeline
2010s
- Jun 1, 2014
Canadian Immunization Research Network— Founded
Drugs by trial phase (15 distinct, 9 trials)
Phase 4 (11 own, 0 via acquisition)
- 23-valent pneumococcal polysaccharide vaccine
- arepanrix
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- pneumococcal 13-valent conjugate vaccine
- hepatitis b vaccine (recombinant)
- human papillomavirus 9-valent vaccine, recombinant
- rsv f vaccine
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- diphtheria toxoid
- tetanus toxoid
Phase 2 (4 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07097012Sponsor investigatorPhase 4Oct 16, 2025
- NCT07097012Lead sponsorPhase 4Oct 16, 2025
- NCT07275060Sponsor investigatorPhase 4Oct 14, 2025
- NCT07275060Lead sponsorPhase 4Oct 14, 2025
- NCT07156084Lead sponsorPhase 4Sep 23, 2025
- NCT04894435Lead sponsorPhase 2May 20, 2021
- NCT03694405Lead sponsorPhase 4Sep 20, 2018
- NCT03384589CollaboratorPhase 2/Phase 3Aug 31, 2018
- NCT03031912CollaboratorPhase 2Jun 30, 2017
- NCT02447718CollaboratorPhase 4Nov 1, 2015
- NCT02169674CollaboratorPhase 4Sep 30, 2014
Details
- Founded
- Halifax, CA Jun 1, 2014
- Last known activity
- Oct 16, 2025